SU2C Innovative Research Grants 2017
The SU2C Innovative Research Grants (IRGs) are an effort to support the next generation of extraordinary leaders in their quest to conquer cancer. The 2017 grants will provide substantial funding to early-career scientists whose novel, high-risk, high-reward immuno-oncology research proposals have significant potential for translational application and hold great promise for advancing SU2C's overarching goal of improving and saving the lives of patients. It is the hope that ideas for new SU2C Dream Teams will emerge from these Innovative Research Grants, and this criterion will be given a high priority in the evaluation of the applications.
To reflect the commitment of SU2C to funding novel approaches, research projects that are already being supported by the National Institutes of Health (NIH) R01 grants, or the equivalent, will not be accepted.
These grants will provide three years of funding of up to $750,000 over the three year grant term to support direct research expenses, depending upon project requirements.
The SU2C Innovative Research Grants will fund novel, high-risk, high-reward immuno-oncology research proposals that have significant potential for translational application and hold great promise for advancing SU2C's overarching goal of improving and saving the lives of patients. Proposals may focus on any discipline within basic, translational, or clinical cancer research, provided that these criteria are met.
Projects that are currently supported by NIH R01 grants, or the equivalent, will not be accepted.
Tenure-track (or equivalent) investigators who are currently in their first independent position, appointed no more than 7 years ago (i.e., on or after May 30, 2010) are eligible to submit a proposal. Postdoctoral fellows, clinical research fellows, or any other researchers-in-training who are working under the direction of a scientific mentor are not eligible to apply.
For institutions that do not follow the traditional tenure system, such as non-academic, non-profit research institutions, tenure-track can be interpreted as a stated commitment from the institution of defined space that the applicant controls, independent of other staff, and defined money over a number of years to support the applicant's research. The nature of the applicant's appointment at the institution in terms of years and salary support must be independent of this or any other grant.
A complete eligibility criteria checklist is provided and must be completed, signed, and submitted with the application.
Applicants must have acquired a medical or other doctoral degree. Applicants must be affiliated with an academic, medical, or research institution within the United States. There are no citizenship or residency status restrictions.
Employees or subcontractors of a U.S. government institution or for-profit industry are not eligible to apply but may be listed as Collaborators. No grant funds may be directed to collaborators working within U.S. government institutions or for-profit industry. Collaborators are optional. Collaborators are independent researchers who have an integral role in the proposed project. Fellows and Research Assistants working on the project are not considered collaborators.
Individuals serving as SU2C Dream Team Leaders or Principals are not eligible to apply.
Candidates with questions about their eligibility are encouraged to contact the AACR's Scientific Review and Grants Administration (SRGA) department at email@example.com prior to submitting an application. Applicants may be asked to submit letters from past and/or present employer(s) to assist in confirming eligibility.
The AACR requires applicants to submit an electronic application via proposalCENTRAL by 12:00 pm (noon), Eastern Time on January 12, 2017, using the proposalCENTRAL website at https://proposalcentral.altum.com.
The SU2C Innovative Research Grants 2017 Program Guidelines are available in PDF format.